IP Library Granted Patent US 7,303,892
Granted Patent B1
US 7,303,892 · App. 10/601,311 · Granted Dec 4, 2007

Crystallization of AKT3

Assignee: Takeda San Diego, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,303,892
App. No.
10/601,311
Granted
Dec 4, 2007
Kind
B1
Abstract

Provided are crystals relating to AKT3 and its various uses.

Claims (28)

1. A composition comprising a protein in crystalline form wherein the protein consists of SEQ ID NO:4, and wherein the protein crystal has a crystal lattice in a P2 1 2 1 2 1 space group and unit cell dimensions, +/−5%, of a=48.36 Å b72.29 Å and c=94.52 Å, α=β=γ=90°.

2. A composition according to claim 1 wherein the protein crystal diffracts X-rays for a determination of structure coordinates to a resolution having a value that is less than or equal to 3.0 Angstroms.

3. A method for forming a crystal of a protein comprising:

forming a crystallization volume comprising a precipitant solution and a protein that consists of SEQ ID NO:4, and wherein a protein crystal is formed that has a crystal lattice in a P2 1 2 1 2 1 space group and unit cell dimensions, +/−5%, of a=48.36 Å b=72.29 Å and c=94.52 Å, α=β=γ=90°; and

storing the crystallization volume under conditions suitable for formation of a protein crystal.

4. A method according to claim 3 wherein a protein crystal is formed that diffracts X-rays for a determination of structure coordinates to a resolution having a value that is less than or equal to 3.0 Angstroms.

5. A non-crystalline protein consisting of SEQ ID NO:4.

6. A non-crystalline protein consisting of residues 136-461 of SEQ ID NO:1.

7. An isolated non-crystalline protein consisting of residues 136-461 of SEQ ID NO:1.

8. An isolated non-crystalline protein consisting of SEQ ID NO:4.

9. A method for obtaining a three dimensional structure of a protein comprising the steps of:

(a) obtaining a crystal of a protein whose sequence consists of SEQ ID NO:4, wherein the protein crystal has a crystal lattice in a P2 1 2 1 2 1 space group and unit cell dimensions, +/−5%, of a=48.36 Å b=72.29 Å and c=94.52 Å, α=β=γ=90°;

(b) using the crystal obtained in step (a) to obtain an x-ray diffraction pattern; and

(c) solving the three dimensional structure of the protein from the diffraction pattern obtained in step (b), thereby obtaining the three dimensional structure of the protein.

10. A method for identifying a compound that binds to a protein comprising the steps of:

(a) obtaining a crystal of a protein whose sequence consists of SEQ ID NO:4, wherein the protein crystal has a crystal lattice in a P2 1 2 1 2 1 space group and unit cell dimensions, +/−5%, of a=48,36 Å b=72.29 Å and c=94.52 Å, α=β=γ=90°;

(b) using the crystal obtained in step (a) to obtain an x-ray diffraction pattern;

(c) solving the three dimensional structure of the protein from the diffraction pattern obtained in step (b), thereby obtaining the three dimensional structure of the protein; and

(d) identifying one or more compounds that binds to the protein based on the three dimensional structure.

11. The method according to claim 10 , further comprising the step of:

contacting one or more compounds identified in step (d) with the protein whose sequence consists of SEQ ID NO:4.

12. The method according to claim 11 further comprising the step of:

measuring an activity of the protein whose sequence consists of SEQ ID NO:4, when the protein is contacted with the one or more compounds.

13. The method according to claim 12 , further comprising the step of:

comparing activities of the protein whose sequence consists of SEQ ID NO:4, when the protein is in the presence of and in the absence of the one or more compounds.

14. The method according to claim 10 , further comprising the steps of:

contacting one or more compounds identified in step (d) with a cell that expresses a protein whose sequence consists of SEQ ID NO:4; and

detecting whether a phenotype of the cell changes when the one or more compounds are present.

Assignments (2)
CHANGE OF NAME Recorded Aug 16, 2006
From: SYRX, INC.
To: TAKEDA SAN DIEGO, INC.
Reel/Frame 018132/0496 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2004
From: ADAM, ERIC; BRODSKY, OLEG; KNUTH, MARK W.; NOWAKOWSKI, JAOEK; PAVIETICH, NIKOLA P.; THOMPSON, DEVON A.; WIJNANDS, ROBERT A.
To: SYRRX, INC.
Reel/Frame 015069/0946 →
Continuity (1)
Provisional Application 6040020700 · Jul 31, 2002